CUMYL-CH-MEGACLONE

CUMYL-CH-MEGACLONE
Legal status
Legal status	CA: Schedule II; DE: NpSG (Industrial and scientific use only); UK: Under Psychoactive Substances Act;
Identifiers
	IUPAC name 2,5-Dihydro-2-(1-methyl-1-phenylethyl)-5-(cyclohexylmethyl)-1H-pyrido[4,3-b]indol-1-one;
CAS Number	2813950-07-9;
PubChem CID	155884822;
ChemSpider	97091815;
UNII	9QA3AM2G3T;
Chemical and physical data
Formula	C27H30N2O
Molar mass	398.550 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)(C1=CC=CC=C1)N2C=CC3=C(C2=O)C4=CC=CC=C4N3CC5CCCCC5;
	InChI InChI=1S/C27H30N2O/c1-27(2,21-13-7-4-8-14-21)29-18-17-24-25(26(29)30)22-15-9-10-16-23(22)28(24)19-20-11-5-3-6-12-20/h4,7-10,13-18,20H,3,5-6,11-12,19H2,1-2H3; Key:CGHCGYCTOLWAPL-UHFFFAOYSA-N;

CUMYL-CH-MEGACLONE (CUMYL-CHMGACLONE, SGT-270) is a gamma-carboline based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first being identified in Hungary in December 2018.^[1]^[2]^[3]

Quick facts Legal status, Identifiers ...

See also